tiprankstipranks
Hims & Hers falls after Hunterbrook Media report on GLP-1 drug sales
The Fly

Hims & Hers falls after Hunterbrook Media report on GLP-1 drug sales

Hunterbrook Media issued a report on Hims & Hers this morning and noted that based on its reporting, Hunterbrook Capital is short the stock. Hims & Hers sells knockoff GLP-1 weight loss drugs through a loophole that could end at any time, Hunterbrook’s Sam Koppelman, Matthew Termine and Michelle Cera report. The journalists say Hims & Hers relies on a sole GLP-1 supplier “with previously unreported ties to fraud and bankruptcy. They note that a Hunterbrook Media reporter qualified for GLP-1 knockoffs from Hims after a four-minute survey, then got a prescription without speaking to a doctor or submitting medical records. The company could suffer legal liability if GLP-1 knockoffs prove unsafe, ineffective, or violate a patent, according to an FDA legal expert, adds Hunterbrook. Hims & Hers shares are down 3% to $21 following the report.

Don't Miss our Black Friday Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App